TY  - JOUR
AU  - Prado, Silvia
AU  - Beltran, Manuela
AU  - Coiras, Mayte
AU  - Bedoya, Luis M
AU  - Alcamí, José
AU  - Gallego, José
PY  - 2016
DO  - 10.1016/j.bcp.2016.02.007
SN  - 0006-2952
UR  - http://hdl.handle.net/20.500.12105/10274
AB  - New antiretroviral agents with alternative mechanisms are needed to complement the combination therapies used to treat HIV-1 infections. Here we report the identification of bioavailable molecules that interfere with the gene expression processes of...
LA  - eng
PB  - Elsevier
KW  - Ciprofloxacin (PubChem CID: 2764)
KW  - Clomiphene (PubChem CID: 1548953)
KW  - Cyproheptadine (PubChem CID: 2913)
KW  - Homochlorcyclizine (PubChem CID: 3627)
KW  - Human immunodeficiency virus type 1
KW  - Mitoxantrone (PubChem CID: 4212)
KW  - Neamine (PubChem CID: 72392)
KW  - Neomycin B (PubChem CID: 8378)
KW  - RNA
KW  - Rev
KW  - Screen
KW  - Transcription
KW  - Anti-HIV Agents
KW  - Cell Line
KW  - Cell Survival
KW  - Clomiphene
KW  - Cyproheptadine
KW  - Drug Evaluation, Preclinical
KW  - Gene Expression Regulation, Viral
KW  - Genes, Reporter
KW  - HIV-1
KW  - High-Throughput Screening Assays
KW  - Humans
KW  - Peptide Fragments
TI  - Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen
TY  - journal article
ER  -